Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Journal of Cachexia, Sarcopenia and Muscle
|
August 7, 2012
Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia
Matteo Cesari, Roger A Fielding, Marco Pahor, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Nature Reviews. Drug Discovery
|
September 23, 2017
Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem
Stephen P Arnerić, Jesse M Cedarbaum, Sean Khozin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 6, 2021
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning
Anat Mirelman, Mor Ben Or Frank, Michal Melamed, et al.
Parkinsonism & Related Disorders
|
September 25, 2021
Seeking progress in disease modification in Parkinson disease
Codrin Lungu, Jesse M Cedarbaum, Ted M Dawson, et al.
Movement Disorders Clinical Practice
|
December 13, 2025
MDS PD e-Diary: A New Patient-Centered Digital Tool in Development for People with Parkinson's Disease
Pablo Rábano-Suárez, Mariana H G Monje, Joaquín A Vizcarra, et al.
JAMA Neurology
|
September 29, 2015
Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial
Vladimir Coric, Stephen Salloway, Christopher H van Dyck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Cinpanemab in Early Parkinson's Disease
Anthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Neurology
|
February 28, 2020
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Journal of Cachexia, Sarcopenia and Muscle
|
August 7, 2012
Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia
Matteo Cesari, Roger A Fielding, Marco Pahor, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Nature Reviews. Drug Discovery
|
September 23, 2017
Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem
Stephen P Arnerić, Jesse M Cedarbaum, Sean Khozin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 6, 2021
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning
Anat Mirelman, Mor Ben Or Frank, Michal Melamed, et al.
Parkinsonism & Related Disorders
|
September 25, 2021
Seeking progress in disease modification in Parkinson disease
Codrin Lungu, Jesse M Cedarbaum, Ted M Dawson, et al.
Movement Disorders Clinical Practice
|
December 13, 2025
MDS PD e-Diary: A New Patient-Centered Digital Tool in Development for People with Parkinson's Disease
Pablo Rábano-Suárez, Mariana H G Monje, Joaquín A Vizcarra, et al.
JAMA Neurology
|
September 29, 2015
Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial
Vladimir Coric, Stephen Salloway, Christopher H van Dyck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Cinpanemab in Early Parkinson's Disease
Anthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Neurology
|
February 28, 2020
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, et al.
Page
of 8